Evaluation of Lipid Profile and Apolipoproteins in Essential Hypertensive Patients

Parsuram Nayak1, Suchismita Panda2, Pravat Kumar Thatoi3

  • 1Senior Resident, Department of Biochemistry, SCB Medical College , Cuttack, Odisha, India .

Insights

Essential hypertension in India is linked to abnormal lipid metabolism. The Apo B100/Apo A1 ratio, alongside traditional lipids, helps assess cardiovascular disease risk in hypertensive patients.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Biochemistry
  • Public Health

Background:

  • Essential hypertension is a prevalent condition in India, significantly contributing to disease burden and mortality.
  • Hypertension is strongly associated with cardiovascular disease and dyslipidemia, involving both traditional lipid parameters and novel components like Apo A1 and Apo B100.

Purpose of the Study:

  • To evaluate serum lipid profiles, including Apo A1 and Apo B100 levels, in essential hypertensive patients.
  • To correlate these lipid parameters with the severity of hypertension.

Main Methods:

  • Fasting blood samples were collected from 55 essential hypertensive patients and 55 matched controls.
  • Tests included plasma glucose, urea, creatinine, lipid profile, Apo A1, and Apo B100.
  • Hypertensive cases were subclassified based on JNC criteria.

Main Results:

  • Hypertensive patients showed significantly higher serum cholesterol, triacylglycerol, LDL, and VLDL, with lower HDL compared to controls.
  • Apo B100 levels were elevated, and the Apo B100/Apo A1 ratio was significantly increased in hypertensive patients.
  • The Apo B100/Apo A1 ratio demonstrated a stronger positive association with systolic and diastolic blood pressure than the LDL/HDL ratio.

Conclusions:

  • The Apo B100/Apo A1 ratio is a valuable complementary marker for assessing cardiovascular disease risk in essential hypertension.
  • This novel lipid parameter aids in risk stratification beyond traditional lipid ratios.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
730
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
800
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
682
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K